Dr Chen-Yu Huang
Postdoctoral Research Fellow
Sydney Medical School
|Telephone||+61 9036 5013|
The efficacy of radiotherapy is decreased by tumour motion. If left uncorrected, this motion causes the radiation beam to miss the tumour, compromising cancer control and increasing toxicity. Dr. Chen-Yu Huang is developing the world’s first radiotherapy system capable of measuring and adapting to tumour motion during treatment. This innovative system will lead to high precision cancer radiotherapy, increasing survival and quality of life for the 44,000 Australian cancer radiotherapy patients every year.
Real-time image guidance; kilovoltage image; tumor motion; motion managment; prostate tumor; lung tumor
Radiobiology; radioimmunotherapy ; Monte Carlo; endothelial cell
Teaching and supervision
Geant4 Monte Carlo simulation
-- Quantify prostate and lung tumor rotation during radiation therapy
-- Design and develop new procedures to commission a 6 degree-of-freedom motion platform – Hexamotion
-- Perform quality assurance for the Kilovoltage Intrafraction Monitoring clinical trial for prostate cancer
-- Develop the real-time 6 degree-of-freedom tumor motion measurement system
-- Develop the real-time 6 degree-of-freedom tumor motionadaptationsystem
- Real-time six degree of freedom tumour motion management in cancer radiotherapy; Huang C, Booth J, Fahrig R, Poulsen P, Kneebone A, Eade T; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.
- Learning Image Context for Tumor Motion Adaptation to Improve Cancer Radiotherapy Treatment Outcomes; Huang C, Keall P, Fahrig R, Wang X; DVC International/IPDF Grant.